Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT)-Reference-Cited by-同舟云学术

Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT)

Published:2023 Issue:2 Volume:34 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Li Yang¹²^ORCID,Zhu Changkun¹^ORCID,Xie Hongyu³^ORCID,Chen Yaxia¹^ORCID,Lv Weiguo¹⁴⁵^ORCID,Xie Xing⁴^ORCID,Wang Xinyu⁴⁵^ORCID

Affiliation:

1. Department of Gynecology and Oncology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

2. Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

3. Department of Clinical Research Center, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

4. Women’s Reproductive Health Key Laboratory of Zhejiang Province, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

5. Cancer Center, Zhejiang University, Hangzhou, Zhejiang, China.

Publisher

XMLink

Subject

Obstetrics and Gynecology,Oncology,General Medicine

Link

https://ejgo.org/pdf/10.3802/jgo.2023.34.e37

Reference30 articles.

1. Integrated genomic characterization of endometrial carcinoma

2. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

3. Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations

4. National Comprehensive Cancer Network. Uterine neoplasms (Version 1. 2022) [Internet]. Plymouth Meeting, PA. National Comprehensive Cancer Network. 2021. cited 2021 Apr 11. Available from: https://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf

5. Clinical actionability of molecular targets in endometrial cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unsolved Issues in the Integrated Histo-Molecular Classification of Endometrial Carcinoma and Therapeutic Implications;Cancers;2024-07-04

2. Old Issues and New Perspectives on Endometrial Cancer Therapy: How Molecular Characteristics Are Changing the Therapeutic Pathway;Cancers;2024-05-14